Preoperative plasma D-dimer level is an independent prognostic factor in patients with completely resected non-small cell lung cancer

Surg Today. 2015 Jan;45(1):63-7. doi: 10.1007/s00595-014-0894-4. Epub 2014 May 1.

Abstract

Purpose: The plasma D-dimer (D-dimer) level, a marker of hypercoagulation, has been reported to be associated with survival in several types of cancers. This retrospective study was conducted to evaluate the prognostic significance of the preoperative D-dimer level in patients with completely resected non-small cell lung cancer (NSCLC).

Methods: A total of 237 completely resected NSCLC patients were included in this study. In addition to age, sex, the smoking status, etc., the association between the preoperative D-dimer level and survival was explored.

Results: The patients were divided into three groups according to the D-dimer level: group A (≤ 0.50 μg/ml, n = 76), group B (0.51-0.86 μg/ml, n = 79) and group C (>0.86 μg/ml, n = 82). The 5-year overall survival rate was 89.6 % (95 % confidence interval (CI) 77.7-95.3) for group A, 75.1 % (95 % CI 62.3-83.6) for group B and 60.1 % (95 % CI 46.8-71.1) for group C (P trend <0.001). A multivariate survival analysis showed that the D-dimer level (group B vs. group A HR 4.25, group C vs. group A HR 4.11) was an independent significant prognostic factor, in addition to age, sex, the pathological stage and the serum carcinoembryonic antigen level.

Conclusions: The preoperative D-dimer level is an independent prognostic factor in patients with completely resected NSCLC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / blood*
  • Carcinoembryonic Antigen / blood
  • Carcinoma, Non-Small-Cell Lung / diagnosis*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Carcinoma, Non-Small-Cell Lung / surgery*
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis*
  • Forecasting
  • Humans
  • Lung Neoplasms / diagnosis*
  • Lung Neoplasms / pathology
  • Lung Neoplasms / surgery*
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Pneumonectomy
  • Preoperative Period*
  • Prognosis
  • Retrospective Studies

Substances

  • Biomarkers, Tumor
  • Carcinoembryonic Antigen
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D